Pilot Grants and Studies
The 好色先生-Alzheimer's Disease Center (ADC) supports one to three pilot studies annually for basic or clinical biomedical, translational, epidemiological, caregiving, educational, or behavioral research.
The annual announcement for pilot funding includes a description of data available through the Use of this resource is strongly encouraged.
This funding mechanism is intended to allow an investigator the opportunity to develop preliminary data sufficient to provide the basis for an application for independent research support. Pilot grants are designed for postdoctoral or junior-faculty level investigators, but may be awarded to a more senior investigator who has experience in areas other than Alzheimer's disease research and who wants to work in the Alzheimer's disease research field or who wants to try a new hypothesis, method, or approach that is not an extension of ongoing Alzheimer's disease research. Pilot studies are typically limited to a non-renewable single year of support. If described and well-justified, two years of support may be requested.
Budget
Investigators may request direct costs up to $25,000 per year for pilot projects. Duration of pilot projects is for one year. Non鈥摵蒙壬 investigators and sites must identify a 好色先生 collaborator and submit the proposal as a subcontract to 好色先生.
好色先生-ADC Pilot Projects 2015-2021
10.1 - Hartz, Anika
Human Blood-Brain Barrier in Alzheimer's Disease: Changes in P-glycoprotein
7/1/15- 6/30/16
10.2 Richards, Allan Christianson and Tietven, Ann
The Impact of a Visual Arts Education (VAE) Pedagogical Strategy on Quality of Life for Individuals with Early Stage Alzheimer's Disease: Dementia and their Caregivers
7/01/15- 6/30/16
11.1 Bachstetter, Adam
Intermittent Hypoxia in Alzheimer's Disease
7/15/16 鈥 6/30/17
11.2: Johnson, Nathan
The Effects of Aging and Ankle Injury on White Matter Integrity and Balance
7/1/16 - 6/30/17
12.1 Bardach, Shoshana
A Participatory Research Endeavor to Promote African American Research Engagement: Photos and Voices to Engage (PREPAARE 鈥 PAVE)
7/1/17 鈥 6/30/ 18
12.2 Duncan, Marilyn
Sleep Enhancement as a Therapeutic Strategy to Combat Alzheimer鈥檚 Disease
7/1/17 鈥 6/30/18
13.1 Dungan, Cory
Obesity- and Exercise-Mediated Alterations in Serum Exosomes that May Affect Brain Pathology in Alzheimer鈥檚 Disease
7/1/18 鈥 6/30/19
13.2 Stamm, Stefan
Are Circular RNAs from the MAPT Locus Translated into Taupolymers?
7/1/18 鈥 6/30/19
14.1 Weekman, Erica
Evaluation of Pathologies Associated with Hyperhomocysteinemia in Human Autopsy Brain Tissue
7/1/19- 6/30/20
14.2 Katsumata, Yuriko
Developing a New Statistical Tool to Examine the Associations between Rare Variants and LOAD-Related Ordinal Phenotype
7/1/19- 6/30/20
15.1 Barbara Nikolajczyk, PhD
鈥淚mmune cell signatures in vascular cognitive impairment and dementia鈥
7/1/20 鈥 6/30/21
15.2 Simone Crivelli, PhD
鈥淚ntra-neuronal accumulation of ceramide drives mitochondria dysfunction in Alzheimer鈥檚 disease鈥
7/1/20 鈥 6/30/21
CCTS 2019 Allison Gibson, MSW, PhD, LISW
鈥淧latform-based MCI trial to address maladaptive behaviors鈥.
CCTS 2020 Pradoldej Sompol, PhD
鈥淐ontribution of activated astrocyte-derived fibronectin to vascular dysfunction in a mouse model of Alzheimer鈥檚 pathology鈥